banner-image-3

Agenda

Day 1 – 20th Feb 2017
  0830-0900   Registration      
  0900-0915   Welcome   Dr. Heidi Larson (LSHTM) & Dan Irvine (World Vision)
Dr. Pierre Meulien (Executive Director, IMI) (video address)
 
  0915-0945   Opening Comments   Ambassador George Hodgson (British Embassy, Dakar)
David Nabarro (Former UN Special Envoy on Ebola)
Elhadj As Sy (Secretary General, IFRC)
 
  0945-1000    Opening Address   Prof. Awa Marie Coll Seck (Minister of Health and Social Action, Senegal)  
Break
  1030-1115   Ebola Research   Dr. Amadou Sall (Director, Pasteur Institute, Dakar)  
  1115-1215    Addressing rumours   Prof. Alex Dodoo (African Collaborating Centre for Pharmacovigilance, Ghana); Prof. Fred Wabwire-Mangen (Makerere University, Uganda); Thomas Mooney (LSHTM); moderator Umaru Fofana (BBC/Reuters)  
Lunch
  1330-1430   Navigating ethics of trials in outbreak settings   Hilde deClerk (Médecins Sans Frontières); Dr. Morenike Folayan (Obafemi Awolowo University, Nigeria); Dr. Annette Rid (King’s College London); Dr. Muhammed Afolabi (LSHTM); Dr. Aissatou Toure (Pasteur Institute, Senegal); moderator Gillian McKay (LSHTM)  
  1430-1515    Information technologies   Monica Amponsah (Grameen Foundation, Ghana); Kamalika Sen (SAATHII, India);  Jamie Bedson (Consultant to Gates Foundation); Romain Rutten (Janssen Global Public Health); Geoffrey Babughirana (World Vision); moderator Karoline Beronius (EIT Digital)  
Break & Technology Demos
  1600-1700   Socio-cultural-political context   Angus Fayia Tengbeh (COMAHS, Sierra Leone); Prof. Sylvain Landry Faye (Cheikh Anta Diop University, Senegal); Luisa Enria (University of Bath, UK); moderator Dr. Shelley Lees (LSHTM)  
  1700-1800   Engaging communities – recruiting participants   Abdul Tejan Deen (COMAHS, Sierra Leone); Julia Lysander (PREVAIL, Liberia); Gaudensia Mutua (KAVI, Kenya); Paramount Chief Bai Farama Tass Bubu N’gbak IV (Magbema Chiefdom, Kambia, Sierra Leone); Stacey Hannah (AVAC); Dr. Glenn Laverack (UNMEER); moderator Dr. Elizabeth Smout (LSHTM)  
Dinner
 
Day 2 – 21st Feb 2017
  0915-1015   Country perspectives on key issues   Richard Zeon (Ministry of Health and Social Welfare, Liberia), Lansana Conteh (Ministry of Health and Sanitation, Sierra Leone); Dr. Diallo Mamadou Rafi (National Health Promotion Services, Guinea); facilitated by Prof. Sir Brian Greenwood (LSHTM)  
Break
  1045-1145   Politics & public trust: Lessons for future trials   Davis Nwakanma (MRC, The Gambia); Prof. Souleyman Mboup (Le Dantec Hospital, Dakar); Soka Moses (PREVAIL, Liberia); Valerie Oriol Mathieu (Janssen Infectious Diseases & Vaccines); Jules Millogo (Merck Vaccines); moderator Janet Tobias  
  1145-1215   Closing address: Preparedness for the future
  Prof. Peter Piot (Director, LSHTM)  
  1215-1230   Thank you and official close of meeting      
Lunch

 

Event Description

EBODAC (Ebola vaccine Deployment, Acceptance and Compliance) is developing strategies and tools to promote the acceptance and uptake of new Ebola vaccines. In this context, the EBODAC consortium is organising a symposium to gather experts from around the world to discuss communications, community engagement strategies, technologies and messaging platforms used in clinical trials during the Ebola outbreak.

This symposium is intended for those working in clinical research, governments and partner organisations in countries hosting clinical research and those with specific expertise in executing community engagement or communication strategies or applying technologies in the clinical trial context.

EBODAC is a collaboration of London School of Hygiene & Tropical Medicine, Janssen Pharmaceutical Companies of Johnson & Johnson, World Vision Ireland and Grameen Foundation, and was set up as part of the Innovative Medicines Initiative’s Ebola+ Programme.

Organisers and Additional Information

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement EBODAC (grant nr. 115847). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Print

Selected Speaker Biographies

Dr. Awa Marie Coll Seck

Awa Marie Coll Seck has served as Minister of Health of the Republic of Senegal since 2012. She was Executive Director of the Roll Back Malaria Partnership (RMB) from 2004-2011 and served as Director of the UNAIDS Department of Country and Regional Support from 1996-2001. She was Minister of Health and Prevention of Senegal from 2001 to 2003.

Dr Coll Seck was elected as chairperson of Committee B of the World Health Assembly and also as president of the Assembly of the Ministries of Health of the West African Health Organization in 2002. She has been awarded numerous professional and academic honours, including the Knight of the Order of Merit of the French Republic, Chevalier, Ordre des Palmes académiques; Officer of the Order of Merit Senegalese; and Knight of the Order of Merit of Burkina Faso. She is an honorary member of the Academy of Sciences and Technologies of Senegal and is the author of more than 150 scientific publications. Dr Coll Seck earned her medical degree from the University of Dakar in 1978.

Prof. Peter Piot

Peter Piot is Director of the London School of Hygiene & Tropical Medicine and Professor of Global Health. He was formerly Under Secretary General of the United Nations and founding Executive Director of UNAIDS, and President of the International AIDS Society. In 1995, he was knighted as a Baron in his native Belgium.

Dr Piot has a medical degree from the University of Ghent (1974), and a PhD in Microbiology from the University of Antwerp (1980). In 1976 he co-discovered the Ebola virus in Zaire while working at the Institute of Tropical Medicine in Antwerp, Belgium. He was a professor of microbiology, and of public health at the Institute of Tropical Medicine, Antwerp, the Free University of Brussels, and the University of Nairobi, was a Senior Fellow at the University of Washington, a Scholar in Residence at the Ford Foundation, and a Senior Fellow at the Bill and Melinda Gates Foundation. From 1991 to 1994 he was president of the International AIDS Society.

Dr. Amadou Sall

Amadou Sall is a virologist and has a PhD in Public health. He is currently the head of the Arboviruses and viral hemorrhagic fever unit, director of the WHO collaborating center and scientific Director of Institut Pasteur de Dakar (IPD). His research focuses primarily on diagnostics, ecology and evolution of arboviruses and viral hemorrhagic fever. He has published more than 100 papers, chapters, a book on viral diagnostics and gave more than 200 scientific communications in international meetings. Dr Sall is a consultant and member of several expert committees for WHO, OIE and vice chair of the Global Outbreak Alert and Response Network steering committee. He is a member of the Senegal National Academy of Science and Technology and has been recipient of the Senegal Presidential Award for Science in 2011 and the UNESCO Prize for Research in Life science in 2015.

Elhadj As Sy

Elhadj As Sy is the Secretary General of the International Federation of Red Cross and Red Crescent Societies. He began this leadership role on 1 August, 2014 and is based at the IFRC secretariat in Geneva, Switzerland. Mr. Sy has extensive experience in leadership roles in the humanitarian sector, having previously served at a senior level with UNICEF, UNAIDS, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and other agencies for more than 25 years.

Before joining the IFRC, Mr. Sy was UNICEF’s Director of Partnerships and Resource Development in New York. He has also served as UNICEF Regional Director for Eastern and Southern Africa and Global Emergency Coordinator for the Horn of Africa. Mr. Sy holds a Bachelor’s Degree in Arts and Human Sciences from the University of Dakar. He then pursued Master’s studies in Arts and Germanistik at the University of Graz, and graduated from the Diplomatic Academy in Vienna.

Recommended Reading

WHO 2018
S Browne, T Carter, R Eckes, 2018 Contemporary Clinical Trials Communications Vol11: 50–54
AJ London, et al. 2018 PLoS Negl Trop Dis Vol 12 (5): e0006313. https://doi.org/10.1371/journal. pntd.0006313
ED Perakslis Conflict and Health 12:23
WHO 2017
G.S. Larson et al 2017 Am. J. Trop. Med. Hygiene 97(1) :10–15 doi:10.4269/ajtmh.16-1015
D Schopper, R Ravinetto, KU Leuven, L Schwartz, E Kamaara, et al. 2017 Public Health Ethics. VOL 10(1):49–61
G Laverack & E Manoncourt. 2016. Global Health Promotion. 23(1): 79-82. doi: 10.1177/1757975915606674. Epub 2015 Oct 29.
Richardson T, Johnston AM, Draper H . 2017 PLoS ONE 12(1): e0168975. doi:10.1371/journal.pone.0168975
EXECUTIVE BOARD EB140/9 140th session
HC Lane, HD Marston,AS Fauci 2016 Clinical Trials Vol. 13(1) 92–95
P Oosterhoff and A Wilkinson 2015 IDS PRACTICE PAPER IN BRIEF 24
A M Gillespie, R Obregon, R El Asawic, C. Richey, EManoncourt, K Joshi, SNaqvi, A P, Naqibullah Safi, K Chitnis, S Quereshi 2016 Glob Health Sci Pract vol. 4 no. 4: p. 626-646 doi: 10.9745/GHSP-D-16-00226
S Vong, R Samuel, P Gould, H El Sakka, BJ Rana, V Pinyowiwat, S Bezbaruaha & R Ofrina. 2016. WHO Bulletin. 94: 913-924.
I Chun-Hai Fung, CH Duke, KC Finch, KR Snook, P Tseng, AC Hernandez, M Gambhir, K Fu, ZT Ho Tse. 2016. American Journal of Infection Control. 44(12): 1660–71. doi: 10.1016/j.ajic.2016.05.011
Topolovec-Vranic, J, Natarajan, K. 2016 JOURNAL OF MEDICAL INTERNET RESEARCH vol. 18 | iss. 11 | e286 | p.2
Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore y Piontti A, et al. 2016 PLoS Negl Trop Dis 10(11): e0005093. http://dx.doi: 10.1371/journal.pntd.0005093
Sharareh N, S. Sabounchi N, Sayama H, MacDonald R. 2016 PLOS Currents Outbreaks. Edition 1 doi: 10.1371/currents.outbreaks.23badd9821870a002fa86bef6893c01d.
Zhao J, Freeman B. 2016 J Med Internet Res 18(11):e287 doi:10.2196/jmir.5692
Halsey E.S. 2016 Am. J. Trop. Med. Hyg. 95(5): 988–992 doi:10.4269/ajtmh.16-0245
Folayan MO, Haire BG, Brown B. 2016 Risk Management and Healthcare Policy 9: 55—65
World Health Organization. 2016. Report.
GOAL. 2016. Conference Report.
Bridget Haire, Morenike Oluwatoyin Folayan. 2016. American Journal of Public Health. September 2016. DOI: 10.2105/AJPH.2016.303311
Morenike Oluwatoyin Folayan, Aminu Yakubu, Bridget Haire, and Kristin Peterson. 2016. BMC Medical Ethics. 17(1).
Vinh-Kim Nguyen. 2014. Cultural Anthropology. Ebola in Perspective.
  • Recent Posts